close

Dr. Faraz Farishta

M.B.B.S., D.N.B.(General Medicine), Diploma in Diabetology Dip.DIAB., PGDip in Endocrinology,Masters In Medical Sciences (MMSC)

HOD & CHIEF ENDOCRINOLOGIST

Consultant Endocrinologist

About Dr. Faraz Faristha

ACADEMIC APPOINTMENTS:

  • October 2016- Programme chair for Masters course  in Diabetes & Metabolism by texilla American University
  • April 2016-Advisory Board member for Target to Treat Hypertension and formation of Indian hypertension guidelines .
  • Mar2016-Faculty for Endo Sphere Programme  in association with Endocrine Society ,USA
  • Feb 2016-   Examiner For MBBS final year Exam appointed by NTR University of Health Sciences
  • Jan 2016-   Faculty :National Diabetes Educator Programme
  • Jan 2015   present    Academic Co coordinator: Maxcure Mediciti Hospital
  • Dec  2013 –present Associate Professor in Mediciti Institute of Medical Sciences
  • Dec’ 2014  -Certified Speaker for Masters in Diabetes  by Harvard Medical School
  • June 2013 – July 2014 Certificate of Recognition from Indian Association Of Diabetes as Speaker for NDEP (National Diabetes Education Program) for Doctors & paramedical staff by IDF (International Diabetes Foundation)
  • Nov 2009  – present Chairman of Diabetes Awareness Foundation Director of SPARSH DIABETIC CENTER.

EDITORIAL APPOINTMENTS

  • October 2015-present Reviewer for Journal of Diabetes and Metabolism
  • August 2015-present Editorial board member of International Journal of Engineering Science and Research
  • June 2014 – Present Editorial Board Member of European Journal of Pharmaceutical and Medical Research
  • Nov 2014 – present  Editorial Board Member of World Journal  of  Pharmaceutical Sciences
  • Nov 2013 – present Reviewer for Journal of Evidence based Medicine & Health care

EDUCATION:

  • May 2013 Masters In Medical Sciences (MMSC)  in Endocrinology (USA), Texilla American University Affiliated by AACE
  • April 2014 PGDip in Endocrinology ( University Of South Wales ) UK ,Affiliated by IDF (International Diabetes Federation )
  • May 2007 Diploma in Diabetology Dip.DIAB. Annamalai University,Chennai, India.
  • April 2006 Diplomate National Board of Medical Education in Internal Medicine(2006) D.N.B.(General Medicine)Osmania Medical College, Koti, Hyderabad.
  • May 2002 Bachelor of Medicine and Bachelor of Surgery M.B.B.S. (2002) Deccan College of Medical Sciences, Kanchanbagh, Hyderabad.

MEMBERSHIP AND CERTIFICATION OF HONOURARY SOCIETY

  • Member Of National Academy Of Medical Sciences
  • Member Of Diabetic Foot Society Of India
  • Member Of RSSDI
  • Member Of API
  • Member Of IMA
  • Member Of ESI (Endocrine Society of India)
  • Member Of BTF (British Thyroid Foundation)
  • Member Of ENDOCRINE SOCIETY (USA)
  • Member Of Indian Thyroid Society
  • Member Of American Association Of Clinical Endocrinologists

    ACADEMIC HONOURS AND AWARDS

  • Awarded with Prestigious “Abdul Kalam Memorial Award” in field of Endocrinology by Telugu Academy of  Telangana
  • Distinction in Premedical Education: Intermediate
  • All India First in Undergraduate Psychiatric Quiz
  • All State First in Undergraduate Pediatric Quiz
  • All State Topper in Gynecology and Obstetrics in MBBS, NTR UHS.
  • Silver Medal in D.N.B. General Medicine
  • Best Post Graduate Medical Student from South India

    CLINICAL AND ACADEMIC EXPERTISE

  • Specialist in Diabetes Control and Management
  • Specialist in Arterial and Venous Doppler Studies in Diabetic patients
  • Specialist in Diabetic Foot Care.
  • Specialist in Managing Endocrine Emergencies
  • Specialist in Gestational Diabetes Mellitus
  • Specialist in Managing Diabetic & Endocrine  Emergencies.
  • Specialist in Managing Thyroid disorder
  • Specialist in Managing metabolic disorder & obesity
  • Specialist in Osteoporosis Management
  • Specialist in Managing Adrenal Disorders

    ORAL RESEARCH PRESENTATIONS

    • Gestational Diabetes Mellitus Is Metformin Safe
    • Diabetes And Nutrition
    • Diabetes And Dyslipedemia, Tashkent, Russia-Youngest International Speaker
    • Diabetes And Dyslipidemia A Review
    • Diabetes And Dyslipidemia Latest Updates
    • Diabetes And Dyslipidemia, Interrelationship
    • Thyroid Management In Pregnancy
    • Diabetes And Metabolic Syndrome
    • Snake Bite:Clinical Features And Management
    • Poisoning :Clinical Features And Management
    • Hiv And Opportunistic Infections
    • Primary Pulmonary Hypertension
    • Diabetes And Stroke
    • Diabetic Ketoacidosis,Management Updates.,B.M.J.2011.
    • Managing Type 2 Dm Intelligently With Dpp4 Inhibitors
    • Are All Dpp4 Inhibitors Same ?
    • Insulin First Line Therapy For Diabetes
    • Role Of Beta Blockers In Type 2 Dm
    • Comprehensive Dm Management
    • Gdm Diagnosis And Management
    • Basal Insulin Therapy New Prospective
    • Are All Sartans Equal
    • Role Of Vogilibose In Ppg Management
    • Use Of Insulin Analogue In Day To Day Practice
    • Management Of Pcos
    • Glycemic Control And Beyond
    • Shifting From Oha Combinations To Insulin
    • Indian Insulin Guidelines
    • Intensification Of Insulin Treatment
    • Optimal Insulin Regimens In Diabetes
    • Hyperurecemia And Role Of Febuxostat
    • Hypothyroidism And Dyslipidemia
    • Subclinical Hypothyroidism Is It Underdiagnosed
    • Diabetes Complications And Management In Ramzan
    • Vitamin D And Bone Health
    • Osteoporosis And Its Management
    • Management Of Diabetes In Icu & In Surgical Patients
    • Maintaining Euglycemia In Type 2 Diabetic Patients In Ramzan
    • Obesity And Its Management
    • Diabetes Masters Programme Certified By Howard Medical School
    • Role Of Premix Insulin In Type 2 Dm Patients In Ramzan
    • Management Of Diabetes In Icu Patients
    • Ppg And Cad A Preventable Duo
    • Role Of Voglibose And Metformin In Treatment Of Type 2 Dm
    • Management Of Type 2 Dm An Indian Prospective
    • Oads : Focus On Cardio-Renal Safety
    • Dpp4 Is: Earlier The Better
    • Revisiting Cv Safety In Oad
    • Diabetes And Cardiovascular Disease A Deadly Duo
    • Addisons disease and its clinical presentations
    • Thyroid disorders whats new
    • Sgl2Inhibitors the new wonder drug
    • Osteoporosis and vitamin D
    • Thyroid disorders what u need to know
    • Basal insulin intiation whats new
    • Thyroid disorders in Pregnacy
    • Vitamin D and its Metabolic Implications
    • Empareg trial outcome and cardiovascular safety of Empagliflozin
    • Management of hypothyroidism and hyperthyroidism
    • Endo 2015 guidelines on treating Thyroid disorders
    • Pcos and Infertility
    • Type2DM and NAFLD
    • Sword to control Diabetes, New frontiers in Diabetes Management  (webinar done across 110 centers in India ,attended by over 1000 doctors )
    • Antithyroid drugs how long and how much
    • Is early combination of Type Dm really beneficial
    • Biosimilars whats new
    • Insulin resistance and its implications
    • Dyslipidemia case scenarios
    • Growth disorders
    • Diabesity and metabolic syndrome
    • Diabetes survey in school children
    • Type 1 dm and hypothyroidism
    • Role of premix insulin during period of ramzan
    • New  managements in Dyslipidemia
    • Newer insulins vs conventional Insulins (which is better )
    • Subclinical hypothyroidism and Pregnancy
    • Graves disease what clinicians should know
    • Erectile dysfunction and diabetes
    • Thyrotoxic crisis and how to manage it
    • Acute adrenal insufficiency is it really common
    • Cushings syndrome vs cushings disease
    • Testosterone replacement therapy
    • Primary hypogonadism and its management
    • Obstructive sleep apnea hypopnea syndrome and diabetes
    • Diabetes global crisis
    • Hypercalcemia and hypocalcemia
    • Hyperprolactinemia whats new in management
    • Growth hormone disorders
    • Approach to short stature
    • Pre dyslipidemia the emerging concepts
    • A comprehensive perspective on Insulin replacement for type 2 diabetes
    • Hypoglycemia and its implications
    • SMBG in pregnancy
    • Diabetes in children
    • Obesity and its management
    • Update on thyroid disorders
    • Metabolic disease what you need to know
    • Are all gliptins equal in cv safety
    • Tailoring and intensifying insulin therapy –overcoming barriers to glycemic control in type2 dm
    • Challenges in Management of Thyroid disorders
    •  pneumococcal vaccination in type2 dm
    • sgl2 inhibitors canagliflozin 300 mg and canvas trial outcomes
    •  role of Insulin degludec asp  in clinical practice

     

    PUBLICATIONS

    1.Olmesartan Medoxomil Evaluated for Safety and Efficacy in Indian Patients with Essential Hypertension : A Real World Observational Post marketing Surveillance published in JAPI February 2010 | Volume 58
    2.OBSTRUCTIVE SLEEP APNEA HYPOPNEA SYNDROME (OSAHS): A CASE REVIEW, Int. J. Pharm. Med. & Bio. Sc. 2014 Faraz Farishta et al., 2014
    3.CHRONIC BUDD CHIARI SYNDROME WITHPROBABLE ETIOLOGY OF OBSTRUCTION BEING A MEMBRANOUS OCCLUSION OF VENA CAVA(MOVC) WITH SECONDARY CHRONIC LIVERDISEASE (NCPF) LEADING TO PORTAL HYPERTENSION: A CASE REPORT ISSN 2278 – 5221 www.ijpmbs.com Vol. 3, No. 4, October 2014
    4.Universal Journal of Pharmacy Take Research to New Heights: UNDERSTANDING SEIZURES IN DIABETES

    Farishta Faraz1*, Shaik Abdul Suhale2

    1 Assistant Professor, Department of Internal Medicine, Mediciti institute of Medical sciences, Hyderabad, India

    2 Registrar, Internal Medicine, Mediciti institute of Medical sciences, Hyderabad, India

    Received 06-12-2014; Revised 04-01-2015; Accepted 02-02-2015
    5.Universal Journal of Pharmacy Take Research to New Heights: A STUDY OF PHOSPHOROUS LEVELS AS A PROGNOSTIC

    INDICATOR IN DIABETIC KETOACIDOSIS

    Farishta Faraz*, Hadi Mohammed Salman2, Mohammed Mudassir2

    1Chief Endocrinologist, Department of Endocrinology, Medwin Hospital, Hyderabad, AP, India

    2 Registrar, Department of Internal Medicine, Medwin Hospital, Hyderabd, AP, India
    Received 24-02-2015; Revised 22-03-2015; Accepted 20-04-2015
    6.Integrative Obesity and Diabetes Integr Obesity Diabetes, 2015 doi: 10.15761/IOD.1000123 Volume 1(4): 101-102 ISSN: 2056-8827 Insulin resistance and thyroid hypofunction in obese women – A cross sectional study Faraz Farishta* and Shaista Farishta Department of Endocrinology, Sparsh Endocrinology and Diabetic Center, India
    7.EJPMR EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 2015,2(4), 1011-1016 SJIF Impact Factor 2.026 Review Article ISSN 3294-3211
    DEMENTIA IN DIABETES: A REVIEW Dr. Faraz Faristha* 1, Dr. Mohammed Salman Hadi 2, Dr. Mohammed Mudassir3

    1 Consultant Endocrinologist. Mediciti Hospital, Hyderabad, India.

    2 Registrar, Department Of General Internal Medicine Mediciti Hospital.

    3 Registrar, Department Of General Internal Medicine, Mediciti Hospital.
    Article Received on 14/06/2015 Article Revised on 05/07/2015 Article Accepted on 26/07/2015
    8.European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) SJIF Impact Factor: 2.062 Manuscript No: EJBPS/951//2/2015 TITLE: LIPID PROFILE IN TYPE 2 DIABETES MELLITUS

    Dr. Faraz Farishta 1, Rahul Reddy 2.

    1 Consultant Endocrinologist Maxcure  Medicti Hospital

    2 Senior Resident Department of Internal Medicine, Maxcure Mediciti Hospital

     

    9.Diabetes & Metabolism

    Journal of Diabetes & Metabolism

    ISSN: 2155-6156

    Farishta and Hadi, J Diabetes Metab 2015, 6:11

    http://dx.doi.org/10.4172/2155-6156.1000621

    J Diabetes Metab Volume 6 • Issue 11 • 1000621

    ISSN: 2155-6156 JDM, an open access journal

    Acromegaly: A Case Study

    Faraz Farishta1* and Mohammed Salman Hadi2

    1Consultant Endocrinologist, Maxcure Mediciti Hospital, Hyderabad, India

    2Consultant Physician, Maxcure Mediciti Hospital, Hyderabad, India
    10.European Journal of Pharmaceutical and Medical Research RARE CAUSE OF REFRACTORY TETANY – PSEUDOHYPOPARATHYROIDISM Gautam Panduranga* 1 , Faraz Farishta2 and Siddhartha Mullapudi3 1Assistant Professor, Department of Medicine, Mediciti Medical College, Telangana. 2Associate Professor, Department of Medicine, Mediciti Medical College, Telangana 3 Postgraduate Resident, Department of Medicine, Mediciti Medical College, Telangana. Article Received on 03/01/2016 Article Revised on 24/02/2016 Article Accepted on 15/03/2016

  • Research Paper Volume : 6 | Issue : 6 | June 2016 | ISSN – 2249-555X | IF : 3.919 | IC Value : 74.50 714 X INDIAN JOURNAL OF APPLIED RESEARCH Carotid Intima-Media Thickness in Patients With Chronic Kidney Disease Dr. ARUN KUMAR PONNA Dr. FARAZ FARISHTA Assistant Professor, Department of Internal Medicine, Mediciti institute of Medical sciences, Hyderabad, India Associate Professor, Department of Internal Medicine, Mediciti institute of Medical sciences, Hyderabad, India Medical Science

    PAPER PRESENTATIONS

  • Gestational Diabetes Mellitus
  • Diabetes and Nutrition
  • Snake Bite: Clinical features and Management
  • Seizures in Diabetes Mellitus’s Review.
  • Dementia in Diabetes Mellitus  Review

     RESEARCH PROJECTS:

  • Principal Investigator for A Cross Sectional ,Clinico-Epidemiological,Multicenter study to determine the Prevalence of Non Alcoholic Fatty Liver Disease and Thyroid Dysfunction in patients with Metabolic Syndrome ,visiting the Endocrinology and Gastroenterology Departments of Tertiary Health Care Centers in India
  • Principal Investigator for  A Multicentric, Randomized, Open Label, Comparative, Parallel assignment Clinical Trial to Evaluate the Safety and Efficacy of Fixed Dose Combinations (FDC) of Repaglinide (0.5mg / 1mg) + Voglibose (0.2mg / 0.3mg) tablets Versus Repaglinide (0.5mg / 1mg) tablets in Patients with Type 2 Diabetes Mellitus
  • Principal Investigator for A prospective, multicenter, randomized, open-label, parallel-group, active-controlled Phase 3 study compare the efficacy safety and immunogenicity of human insulin biphasic 100 IU (30/70) of MJ  with Humulin® 30/70  in patients diagnosed with type 1 or type 2 diabetes mellitus
  • Principal Investigator for trial comparing efficacy and safety of insulin degludec/insulin aspart twice daily and biphasic insulin aspart twice daily in subjects with type 2 diabetes mellitus before, during  and after Ramadan .
  • Principal Investigator in Central Aortic Pressure(CAP) registry
  • Principal Investigator in IDMPS wave 7 study
  • Principal Investigator for Diabetes and Nephropathy Phase 2 Trial
  • Principal Investigator for Hypertension and Nephropathy Phase 2 Clinical Trial
  • CO Investigator for Diabetes and Osteoarthritis Phase 3 Clinical Trial
  • Hemorrhagic vs Ischemic Stroke in Diabetes Clinical Trial
  • Co-Investigator in Ahead trial for Rasilez.
  • Co-Investigator in role of Pre mix Insulin in Diabetes Mellitus

Quick Contact Form


Enquiry Now
"A Health Check Today May Prevent Worries of Tomorrow" -Executive Health Checkup Package @ Rs. 2999/- | Master Health Checkup Package @ Rs. 1999/- | For more details please free to contact us on 040 4940 4940 css